An Endocannabinoid Enzyme Inhibitor Lost Pain-Related Activity With Repeated Dosing

THC Vaporized and THC edibles

An experimental enzyme inhibitor produced a different profile after repeated treatment than after a single dose in mice. The finding shows why an acute cannabinoid-related benefit cannot automatically be projected into chronic therapy.

Raising an endogenous cannabinoid

The investigators blocked monoacylglycerol lipase, or MAGL, using JZL184 and compared pharmacological results with genetic MAGL disruption. MAGL normally helps break down the endocannabinoid 2-AG. This approach differs from administering THC or a retail CBD product.

Acute and repeated treatment diverged

Repeated MAGL blockade lost analgesic activity and produced cross-tolerance to selected effects of cannabinoid-receptor agonists. Brain receptor expression, signaling and synaptic-plasticity findings supported adaptation. Cross-tolerance was not equally strong for every endpoint, including catalepsy.

Another enzyme was not equivalent

Sustained inhibition of FAAH, an enzyme involved in anandamide breakdown, showed a contrasting profile with preserved analgesic activity and less receptor adaptation under the tested conditions. Both pathways involve endogenous cannabinoids, but that common label did not predict identical chronic responses.

From mechanism to treatment

These were mouse, tissue and laboratory experiments, not trials showing that a medicine safely treats chronic pain in patients. The dose, extent and duration of enzyme inhibition matter; partial blockade could behave differently from sustained high-level inhibition. The study supports testing chronic efficacy and dependence-related outcomes directly. It does not establish the long-term performance of cannabis, CBD or every endocannabinoid-targeted drug.

Related analysis: evaluating cannabis tolerance claims.

Primary research

Schlosburg JE; Blankman JL; Long JZ; Nomura DK; Pan B; Kinsey SG; Nguyen PT; Ramesh D; Booker L; Burston JJ; Thomas EA; Selley DE; Sim-Selley LJ; Liu QS; Lichtman AH; Cravatt BF. Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system. Nature neuroscience (2010). DOI: 10.1038/nn.2616.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

Why Clothing Belongs in a Body Temperature Record

Saukko and Knight describe clothing and coverings as factors that affect heat exchange after death.

Spread the love

Read Article: Why Clothing Belongs in a Body Temperature Record

How Decomposition Can Produce Blisters and Skin Slippage

Blisters and areas of loose skin can develop during decomposition.

Spread the love

Read Article: How Decomposition Can Produce Blisters and Skin Slippage

Why Pale Areas Can Appear Within Postmortem Lividity

After death, blood settles in dependent areas and may produce a visible discoloration called lividity.

Spread the love

Read Article: Why Pale Areas Can Appear Within Postmortem Lividity

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us